NCT04895696: An ongoing trial by Beeline Medicines Corporation
This trial is ongoing. It must report results 9 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04895696 |
|---|---|
| Title | A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 11, 2021 |
| Completion date | June 12, 2026 |
| Required reporting date | June 12, 2027, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Sept. 9, 2026 |
| Days late | None |